Draft Bottleneck Bill Must Go Further, Urges German Generics Body
Only Targeting Antibiotics And Oncology Will Not Solve Shortages Issue
The German government has released a draft bill to remedy supply chain bottlenecks for antibiotic and oncology drugs, but Pro Generika, the country’s trade association for off-patent drugs, has urged it to apply these proposed changes to all generic medicines.
You may also be interested in...
With Olon investing significantly in its production capacity and technical capabilities, CEO Paolo Tubertini believes the API specialist is well-positioned to provide resilience within the European supply chain. However, the chief executive also told Generics Bulletin that this robustness needs to be valued by pricing mechanisms.
In the third and final part of his exclusive interview with Generics Bulletin, Sandoz CEO Richard Saynor discusses global off-patent industry challenges including antibiotics shortages, PBM behavior in the US and the UK’s VPAS rebate mechanism.
Germany’s Bundesministerium für Gesundheit is reworking the country’s off-patent drug legislation to allow for more flexible pricing.